China · Delayed Price · Currency is CNY Hybio Pharmaceutical Company Description
Hybio Pharmaceutical Co., Ltd. engages in the research, development, production, and marketing of peptide and oligonucleotide drugs in China and internationally.
The company offers finished dosage form (FDF) products for obstetrics and gynecology, haemostatic agent, digestive tract and metabolic systems, immune system modulation, cardiovascular, diabetes mellitus, and osteoporosis, as well as disposable injectable pens; and peptide active pharmaceutical ingredients (API) comprising polypeptides, small molecules and nucleic acids, and intermediates for endocrine, nutritional, and metabolic diseases; digestive system diseases; neoplasms; nervous system diseases; pregnancy, childbirth, and puerperium; musculoskeletal system and connective tissue diseases; infectious and parasitic diseases; circulatory system diseases; blood and hematopoietic organ diseases; and genitourinary system diseases, as well as factors influencing health status.
It also provides contract research, development, and manufacturing organization (CRDMO) services for peptide APIs, peptide formulations, oligonucleotide drugs, and pharmaceutical intermediates.
In addition, the company engages in the provision of property services. Hybio Pharmaceutical Co., Ltd. was founded in 1998 and is headquartered in Wuhan, China.
| Country | China |
| Founded | 1998 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 1,035 |
| CEO | Yu Pinxiang |
Contact Details
Address: Hanyu Innovation Industry Building Wuhan, 518110 China | |
| Phone | 86 755 2658 6015 |
| Website | hybio.com.cn |
Stock Details
| Ticker Symbol | 300199 |
| Exchange | Shenzhen Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE1000011T7 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Shaogui Zeng | President and Chairman |
| Yu Pinxiang | Executive President and Director |
| Honghong Tu | Vice President and Chief Financial Officer |
| Min Zhang | Vice President of Human Resources, Corporate Management and Administrative Department |
| Baole Zhang | Vice President |
| Caiyun Bian | Accounting Supervisor |
| Yu Liu | Vice President of Marketing |